IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

PARRAVICINI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.003
NA - Nord America 7.646
AS - Asia 6.393
SA - Sud America 537
AF - Africa 141
OC - Oceania 56
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 22.781
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.440
CN - Cina 2.086
SG - Singapore 1.999
GB - Regno Unito 1.995
IT - Italia 1.852
DE - Germania 1.554
SE - Svezia 664
HK - Hong Kong 546
RU - Federazione Russa 462
BR - Brasile 402
VN - Vietnam 341
IN - India 312
FR - Francia 310
JP - Giappone 240
BD - Bangladesh 205
DK - Danimarca 191
IE - Irlanda 185
KR - Corea 177
FI - Finlandia 167
NL - Olanda 152
ID - Indonesia 148
CA - Canada 114
UA - Ucraina 78
TR - Turchia 73
CH - Svizzera 59
AU - Australia 54
PL - Polonia 54
BE - Belgio 53
MX - Messico 49
ES - Italia 48
AT - Austria 39
AR - Argentina 37
PK - Pakistan 37
CI - Costa d'Avorio 32
CZ - Repubblica Ceca 28
IQ - Iraq 27
CO - Colombia 25
TW - Taiwan 25
ZA - Sudafrica 20
EC - Ecuador 19
EU - Europa 19
IL - Israele 19
PH - Filippine 19
EG - Egitto 17
IR - Iran 17
UZ - Uzbekistan 17
PT - Portogallo 16
CL - Cile 15
TH - Thailandia 15
GR - Grecia 14
TN - Tunisia 14
UY - Uruguay 13
NO - Norvegia 12
RO - Romania 12
SI - Slovenia 12
MA - Marocco 11
MY - Malesia 11
NG - Nigeria 10
AZ - Azerbaigian 9
JO - Giordania 9
SA - Arabia Saudita 9
VE - Venezuela 9
CR - Costa Rica 8
NP - Nepal 8
SC - Seychelles 8
BO - Bolivia 7
LV - Lettonia 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
GE - Georgia 6
HU - Ungheria 5
JM - Giamaica 5
KZ - Kazakistan 5
LT - Lituania 5
LU - Lussemburgo 5
PA - Panama 5
PY - Paraguay 5
BY - Bielorussia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
ET - Etiopia 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
AW - Aruba 3
BS - Bahamas 3
HR - Croazia 3
KE - Kenya 3
LK - Sri Lanka 3
MO - Macao, regione amministrativa speciale della Cina 3
AL - Albania 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CY - Cipro 2
GH - Ghana 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
LB - Libano 2
NI - Nicaragua 2
Totale 22.754
Salva come PNG Salva come JPEG
Città #
Southend 1.657
Singapore 1.258
Milan 813
Frankfurt am Main 745
Ashburn 681
Chandler 495
Hong Kong 488
Beijing 385
San Jose 384
Fairfield 376
Dallas 338
Wilmington 303
Council Bluffs 257
Ann Arbor 255
Seattle 255
Hanover 251
Princeton 216
Dearborn 215
Cambridge 195
Houston 195
Woodbridge 184
Dublin 175
Los Angeles 158
Redwood City 142
New York 137
Nanjing 134
Santa Clara 129
The Dalles 115
Sunnyvale 107
Tokyo 102
Shanghai 98
Grafing 95
Hanoi 95
Lauterbourg 93
Jakarta 91
Seoul 89
Ho Chi Minh City 88
Guangzhou 84
Bengaluru 81
Helsinki 79
Mountain View 77
Des Moines 76
Hefei 75
Moscow 66
Jinan 65
Boardman 64
Berlin 61
Buffalo 58
Phoenix 58
Medford 56
Rome 54
Shenyang 51
Columbus 50
Boston 43
Hebei 42
Redmond 41
Changsha 38
Munich 38
Warsaw 34
Toronto 33
Abidjan 32
San Diego 32
Tianjin 32
Naples 31
Nuremberg 31
Brussels 30
Hangzhou 30
São Paulo 30
London 29
Bühl 27
Cangzhou 26
Chicago 26
Nanchang 25
Jacksonville 23
Melbourne 23
Rio de Janeiro 23
Zhengzhou 23
Andover 22
Basingstoke 22
Vienna 21
Istanbul 20
Somerville 20
Turin 20
Montreal 19
Shenzhen 19
Jiaxing 18
Fuzhou 17
Ningbo 17
Roxbury 17
Silver Spring 17
Turku 17
Kunming 16
Chennai 15
Chongqing 15
Da Nang 15
Mumbai 15
Ottawa 15
Ponte San Pietro 15
Taiyuan 15
Wuhan 15
Totale 13.993
Salva come PNG Salva come JPEG
Nome #
Pharmacological Properties and Biological Functions of the GPR17 Receptor, a Potential Target for Neuro-Regenerative Medicine 1.210
With or without you - Proteomics with or without major plasma/serum proteins 634
A novel SEMA3G mutation in two siblings affected by syndromic GnRH deficiency 633
Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs 424
Novel insights into the transport mechanism of the human amino acid transporter LAT1 (SLC7A5) : probing critical residues for substrate translocation 415
SLC6A14, a Pivotal Actor on Cancer Stage: When Function Meets Structure 411
A promiscuous recognition mechanism between GPR17 and SDF-1 : molecular insights 363
Surface Plasmon Resonance as a Tool for Ligand Binding Investigation of Engineered GPR17 Receptor, a G Protein Coupled Receptor Involved in Myelination 346
A new strategy of selective Notch receptor targeting in multiple myeloma based on small molecules 329
Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis 328
Enzymatic reduction of acetophenone derivatives with a benzil reductase from Pichia glucozyma (KRED1-Pglu): electronic and steric effects on activity and enantioselectivity 321
Inhibition of Pancreatic α-amylase by Resveratrol Derivatives : Biological Activity and Molecular Modelling Evidence for Cooperativity between Viniferin Enantiomers 309
The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor 306
In silico description of LAT1 transport mechanism at an atomistic level 300
2,4-Furfurylidene-D-sorbitol and its tetra-methyl ether: Synthesis, conformational studies, and radical scavenging activity 288
Deciphering remyelinating mechanisms induced by clinically-used azole antifungals with exploitable repurposing properties : An in silico approach 282
Set-up and validation of a high throughput screening method for human monoacylglycerol lipase (MAGL) based on a new red fluorescent probe 278
Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson's disease 275
N-(phenyl)-2-[[3-(phenyl)-1H-1,2,4-triazol-5-yl]thio]-acetamide derivatives and related compounds as G protein coupled receptor 17 (GPCR17) modulators for use in the treatment of neuro-degenerative diseases 275
Involvement of GPR17 in Neuronal Fibre Outgrowth 274
GPR17 : molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors 273
Identification of small molecules uncoupling the Notch : Jagged interaction through an integrated high-throughput screening 273
All-purpose containers? Lipid-binding protein : drug interactions 272
A new therapeutic strategy in multiple myeloma based on small molecules directed to notch pathway 270
Mechanism of LAT1 amino acid antiport: a molecular dynamics simulation of the behaviour of a solute and of an inhibitor 264
rHDL modelling and the anchoring mechanism of LCAT activation 263
Deciphering and modelling remyelinating mechanisms induced by clinically-used azole antifungals with exploitable repurposing properties 262
Notch-targeted therapeutic strategy in multiple myeloma based on small molecules hampering receptor-ligand interaction 257
An in silico structural approach to critical quality attributes assessment of biopharmaceutical products 245
Inhibition of pancreatic α-amylase by resveratrol-derived viniferins relates to their geometrical features and implies co-operative binding 245
Computational modelling of the LCAT::rHDL complex and bases of LCAT pharmacological activation 245
Design, synthesis, molecular modelling and in vitro cytotoxicity analysis of novel carbamate derivatives as inhibitors of Monoacylglycerol lipase 243
GPR17, a key receptor involved in oligodendrogenesis: implications for re-myelination strategies 237
What if? Mouse proteomics after gene inactivation 237
Gender proteomics. II. Which proteins in sexual organs 232
A novel therapeutic approach targeted notch in multiple myeloma based on small molecules uncoupling receptor-ligand interaction 231
A computational approach to evaluate the androgenic affinity of iprodione, procymidone, vinclozolin and their metabolites 227
GPR17 molecular modelling: interactions with non-conventional pro-inflammatory ligands 227
Targeting the interaction of multiple myeloma and the bone marrow microenvironment through novel small molecules directed to Notch pathway 220
Role of the GM1 ganglioside oligosaccharide portion in the TrkA-dependent neurite sprouting in neuroblastoma cells 216
Mechanism of LAT1 amino acid antiport: a molecular dynamics simulation of the behaviour of a solute and of an inhibitor 215
A novel Notch-targeted therapeutic approach in multiple myeloma based on small molecules disrupting Notch-Jagged interaction 214
Extracellular purine and pyrimidine nucleotides as local extrinsic regulators of adult neural progenitor cells in the diseased CNS 213
Stress Modifies the Expression of Glucocorticoid-Responsive Genes by Acting at Epigenetic Levels in the Rat Prefrontal Cortex : Modulatory Activity of Lurasidone 211
The P2Y-like GPR17 receptor orchestrates the transition between immature and myelinating oligodendrocytes and is a new target for myelin repair 208
Forced unbinding of GPR17 ligands from wild type and R255I mutant receptor models through a computational approach 207
In silico prioritization of endocrine active substances (EAS) and their in vitro validation 207
Mechanism of LAT1 amino acid antiporter: a molecular dynamics simulation of the behaviour of a solute and of an inhibitor 206
Crystal structure and functional characterization of the GPR17 receptor, a novel pharmacological target for remyelination therapy in multiple sclerosis 198
Un approccio computazionale per valutare l'affinità androgenica di iprodione, procimidone, vinclozolin e i loro metaboliti 197
In silico investigations of N-glycosylation role in modulating IgG1 conformational behavior and Fc effector functions 196
Dysregulation of the GPR17 receptor in neuroinflammatory diseases: implications for remyelination in multiple sclerosis 195
Modellng Molecolare e meccanismo di interazione del complesso LCAT-rHDL 189
IgG1 effector functions: elucidation of glycans role by in silico structural analysis 186
Supramolecular modeling of an LCAT-rHDL assembly and cholesterol transesterification mechanism 184
Gpr17-modulating compounds, diagnostic and therapeutic uses thereof 183
Comparative evaluation of GPR17 ligands in silico and in vitro on cultured primary oligodendrocyte precursor cells 182
Molecular modelling in pharmacology: selected examples 180
GM1 neurotrophic properties are related to gm1oligosaccharide - TrkA interaction in mouse neuroblastoma cells 180
Chimeric molecular modeling and high throughput screening of GPR17: towards the identification of new ligands 178
GPR17 Receptor Modulators 177
Gender proteomics I. Which proteins in non-sexual organs 175
The Neurotrophic properties of GM1 oligosaccharide: a new promising story 174
A new strategy for selective NOTCH2 targeting in multiple myeloma based on small molecules hampering receptor-ligand interaction 173
GPR17 Receptor Modulators 169
Gpr17 receptor modulators 168
Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury 166
In silico prioritization for endocrine active substances (EAS) and their in vitro validation 166
In silico identification of new ligands for GPR17 : a promising therapeutic target for neurodegenerative diseases 164
Dysregulation of GPR17, a key receptor involved in NG2 progenitor cells differentiation to mature oligodendrocytes, as a novel potential pathogenetic mechanism in demyelinating diseases 164
Modulatori del recettore gpr17 162
Pharmacological and biotechnological in vitro approaches unveil the role of GPR17 signaling in regulating the timing of oligodendroglial differentiation 158
Supramolecular modelling of an LCAT-rHDL assembly and cholesterol trans- esterification mechanism 158
Forced unbinding of GPR17 ligands from wild-type and R255I mutant receptor models 157
Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation 155
Oxysterols act as promiscuous ligands of class-A GPCRs : in silico molecular modeling and in vitro validation 155
Role of the P2Y-like receptor GPR17 in neural precursor cells 155
IgG1 Effecor functions: elucidation of glycans role by in silico structural analysis 154
GPR17 Receptor Modulators 154
GPR17 Receptor Modulators 149
In silico identification of small molecules engaging the TNFR2-TNF-α interaction: a novel approach for targeting demyelinating diseases 147
GPR17 Receptor Modulators 147
Biotechnological and pharmacological in vitro approaches unveil the role of GPR17 signaling in regulating the timing of oligodendroglial differentiation 146
New Notch-targeted therapeutic strategy to uncouple a pathological interaction of myeloma cells and bone marrow microenvironment using novel small molecules 145
Gene regulation of the P2Y-like receptor GPR17, a key player in oligodendroglial differentiation 141
Frontal Affinity Chromatography-Mass Spectrometry Useful for Characterization of New Ligands for GPR17 Receptor 139
Class A GPCRs: a multifaceted reality 139
Supramolecular modelling of an LCAT-rHDL assembly and cholesterol trans- esterification mechanism 139
The P2Y-like GPR17 receptor regulates the differentiation of NG2+ neural precursor cells into mature oligodendrocytes 138
Time-dependent and critical role of the P2Y-like GPR17 receptor at distinct stages of oligodendrocyte differentiation 138
An in silico integrated pipeline for affinity and intrinsic activity evaluation of estrogen receptor alpha putative ligands 137
IgG1 conformational behavior: elucidation of the N-glycosylation role via molecular dynamics 137
IgG1 conformational behavior: elucidation of the N-glycosylation role via molecular dynamics 134
Time-dependent and critical role of the P2Y-like GPR17 receptor at distinct stages of oligodendrocyte differentiation 133
In silico identification of small molecules engaging the TNFR2-TNF-α interaction: a novel approach for targeting demyelinating diseases 132
Modulatori del recettore gpr17 129
The Dual Behaviour of a GPCR Involved in Brain Damage an Repair: Forced Unbinding of the Receptor GPR17 Ligands from Wild Type and R255I Mutant Models Through a Computational Approach 129
Ventral tegmental area/substantia nigra and prefrontal cortex rodent organotypic brain slices as an integrated model to study the cellular changes induced by oxygen/glucose deprivation and reperfusion : effect of neuroprotective agents 122
Gastrointestinal basidiobolomycosis mimicking a right colon cancer treated using a laparoscopic approach and antifungal therapy 119
Potent inhibitors of human LAT1 (SLC7A5) transporter based on dithiazole and dithiazine compounds for development of anticancer drugs 117
Totale 22.830
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.061
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.061
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021320 0 0 0 0 0 0 0 0 0 0 190 130
2021/20222.368 237 119 132 140 161 214 167 130 155 296 179 438
2022/20232.119 274 180 198 200 243 376 64 140 217 47 113 67
2023/20242.001 76 113 213 222 352 73 151 154 81 133 200 233
2024/20253.301 195 322 154 293 266 129 154 340 172 241 294 741
2025/20266.154 616 416 665 462 570 435 807 324 804 493 562 0
Totale 23.787